Genetron Holdings Limited is a precision oncology company that uses molecular biology and data science to provide diagnosis, monitoring, and early screening services for cancer. They develop in-vitro diagnostic products such as lung cancer assays, biochip reading instruments, and genomic profiling services for various types of solid tumors. The company also collaborates with biopharmaceutical companies and has a strategic partnership with JD Health for full-cycle cancer management solutions.